Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

A novel fluorescent probe for imaging the process of HOCl oxidation and Cys/Hcy reduction in living cells

Zhen Liua, Guoping Li*a, Yana Wanga, Jiulong Lia, Yang Mib, Linna Guoa, Wenjian Xua, Dapeng Zoua, Tiesheng Li*a and Yangjie Wu*a
aThe College of Chemistry and Molecular Engineering, Zhengzhou University, Zhengzhou 450001, Henan Province, P. R. China. E-mail: liguoping@zzu.edu.cn
bSchool of Basic Medical Sciences, Zhengzhou University, Zhengzhou 450001, Henan Province, P. R. China

Received 18th December 2017 , Accepted 23rd February 2018

First published on 5th March 2018


Abstract

A new on-off-on fluorescent probe, CMOS, based on coumarin was developed to detect the process of hypochlorous acid (HOCl) oxidative stress and cysteine/homocysteine (Cys/Hcy) reduction. The probe exhibited a fast response, good sensitivity and selectivity. Moreover, it was applied for monitoring the redox process in living cells.


Reactive oxygen species (ROS) are indispensable products and are closely connected to various physiological processes and diseases.1 For instance, endogenous hypochlorous acid (HOCl) as one of the most important ROS, which is mainly produced from the reaction of hydrogen peroxide with chloride catalyzed by myeloperoxidase (MPO), is a potent weapon against invading pathogens of the immune system.2,3 However, excess production of HOCl may also give rise to oxidative damage via oxidizing or chlorinating the biomolecules.4 The imbalance of cellular homostasis will cause a serious pathogenic mechanism in numerous diseases, including neurodegenerative disorders,5 renal diseases,6 cardiovascular disease,7 and even cancer.8 Fortunately, cells possess an elaborate antioxidant defense system to cope with the oxidative stress.9 Therefore, it is necessary and urgent to study the redox process between ROS and antioxidants biosystems.

Fluorescence imaging has been regarded as a powerful visual methodology for researching various biological components as its advantages of high sensitivity, good selectivity, little invasiveness and real-time detection.10,11 To date, amounts of small molecular fluorescent probes have been reported for detection and visualization of HOCl in vivo and in vitro.12–22,29 The designed strategies of HOCl sensitive probes are based on various HOCl-reactive functional groups, such as p-methoxyphenol,13 p-alkoxyaniline,14 dibenzoyl-hydrazine,15 selenide,16 thioether,17 oxime,18 hydrazide,19 hydrazone.20 But, many of these probes display a delayed response time and low sensitivity. And, only few fluorescent probes can be applied for investigating the changes of intracellular redox status.21 Besides, it's worth noting that most of the redox fluorescent probes rely on the organoselenium compounds.22 Even though these probes are well applied for detection of cellular redox changes, excessive organic selenium is harmful to organisms and the synthesis of organoselenium compounds is high requirement and costly. Additionally, almost all the reports have only investigated the reduction effects of glutathione (GSH) as an antioxidant in the redox events. While, there are the other two important biothiols, cysteine (Cys) and homocysteine (Hcy), which not only present vital antioxidants, but also are tightly related to a wide variety of pathological effects in biosystem, such as slowed growth, liver damage, skin lesions,23 cardiovascular,24 and Alzheimer's diseases.25 However, the fluorescent probes for specially studying internal redox changes between HOCl and Cys/Hcy are rarely reported. In this respect, a novel redox-responsive fluorescent probe, CMOS, was designed and synthesized in this work, and we hope that it can be a potential tool for studying their biological relevance in living cells.

Based on literature research, the aldehyde group has excellent selectivity in identification of Cys/Hcy, and the thiol atom in methionine can be easily oxidized to sulfoxide and sulfone by HOCl.26,27 Considering these two points, we utilized 2-mercaptoethanol to protect the 3-aldehyde of 7-diethylamino-coumarin as the recognition part of HOCl, meaning that two kinds of potential recognition moieties are merged into one site. Fluorescent probe CMOS can be easily synthesized by the acetal reaction in one step (Scheme S1). A control molecule CMOS-2 was also prepared by 3-acetyl-7-diethylaminocoumarin (CMAC) similarly. The structure of all these compounds have been convinced by 1H NMR, 13C NMR, and HR-MS (see ESI).

As shown in Scheme 1a, we estimated that both CMOS and CMOS-2 can be rapidly oxidized in the appearance of HOCl. The oxidation product CMCHO of CMOS, which has the aldehyde moiety, can further react with Cys/Hcy to obtain the final product CMCys and CMHcy, respectively. In contrast, the oxidation product CMAC of CMOS-2 cannot combine with Cys/Hcy or other biothiols anymore (Scheme 1b).


image file: c7ra13419c-s1.tif
Scheme 1 Proposed reaction mechanism of CMOS and CMOS-2 to HOCl and Cys/Hcy.

In order to confirm our design concept, the basic photo-physical characteristics of CMOS, CMCHO, CMOS-2 and CMAC were tested (Table S1, Fig. S1). Under the excitation wavelength 405 nm, CMOS and CMOS-2 exhibited strong fluorescence centred at 480 nm in PBS buffer solution, while the fluorescence of CMCHO and CMAC was weak around this band. The emission properties of CMOS and CMCHO were also investigated at the excitation wavelength 448 nm under the same experimental conditions as well (Fig. S2). After careful consideration, we chose 405 nm as the excitation wavelength in the follow-up experiments in vitro and in vivo.

Next, the sensitivity of CMOS and CMOS-2 to HOCl and Cys/Hcy were investigated. As we expected, both the CMOS and CMOS-2 exhibited good response to HOCl. The fluorescence intensity of CMOS and CMOS-2 decreased gradually with addition of NaOCl (Fig. 1a, S3a), indicating that the fluorescence was switched off obviously in the presence of HOCl. The variation of intensity displayed good linearity with concentration of HOCl in the range of 0–20 μM (R2 = 0.993, Fig. S4), and the detection limit of CMOS to HOCl was calculated to be 21 nM (S/N = 3). Subsequently, when Cys/Hcy was added to the final solution in Fig. 1a, the fluorescence intensity increased gradually within 180 min (Fig. 1b, S5). However, the fluorescence cannot be recovered by addition thiols to the CMOS-2 solution with excess HOCl (Fig. S3b). These results indicate that the probe CMOS can response to HOCl and Cys/Hcy in a fluorescence on-off-on manner, and can be used for monitoring the redox process with high sensitivity.


image file: c7ra13419c-f1.tif
Fig. 1 (a) Fluorescence responses of CMOS (2 μM) to different concentrations of NaOCl (0–200 μM). (b) Fluorescence responses of the CMOS solution (2 μM) with HOCl (200 μM) to Cys/Hcy (5 mM). (20 mM PBS buffer/CH3CN, 7[thin space (1/6-em)]:[thin space (1/6-em)]3, v/v, pH = 7.4, λex = 405 nm).

To further identify the recognizing mechanism of probe CMOS, high performance liquid chromatography (HPLC) and mass spectral (MS) analysis were used to detect the redox process. Initially, probe CMOS displayed a single peak with a retention time at 3.7 min (Fig. 2a, S6) while reference compound CMCHO produced a single peak with a retention time at 2.5 min (Fig. 2b, S7). Upon the addition of HOCl to the solution of CMOS, the peak at 3.7 min weakened while 2.5 min and 2.2 min appeared (Fig. 2c). According to corresponding mass spectra, the new main peak at 2.5 min is related to compound CMCHO (Fig. S8). The other new peak of 2.2 min corresponds to the compound C3, which can be predicted as an intermediate in the oxidation process (Fig. S8).28 The addition of Cys to the solution of CMCHO also caused a new peak with a retention time at 2.1 min, which has been confirmed to be the thioacetal product CMCys (Fig. S9). The possible sensing mechanism is depicted in Fig. S10.


image file: c7ra13419c-f2.tif
Fig. 2 The reversed-phase HPLC with absorption (400 nm) detection. (a) 10 μM CMOS. (b) 10 μM CMCHO. (c) 10 μM CMOS in the presence of 50 μM HOCl for 30 s. (d) 10 μM CMCHO in the presence of 1 mM Cys for 30 min. (Eluent: CH3CN containing 0.5% CH3COOH; 100% CH3CN (0–7 min), 0.5 ml min−1, 25 °C; injection volume, 5.0 μL).

To study the selectivity of CMOS towards HOCl, we performed fluorescence response to different reactive oxygen species (ROS), reactive nitrogen species (RNS) and reactive sulfur species (RSS). As shown in Fig. 3a, CMOS exhibited significant change of fluorescence intensity only in the presence of HOCl, while other ROS and RNS, such as singlet oxygen (1O2), hydrogen peroxide (H2O2), hydroxyl radical (HO·), superoxide anion (O2), nitric oxide (NO), tert-butylhydroperoxide (t-BuOOH) and tert-butoxy radical (t-BuOO·) had no obvious fluorescence emission changes. Additionally, RSS which are abundant in biological samples, showed no influence in this process under the identical condition. The detection of reducing process was also investigated. As displayed in Fig. 3b, only cysteine and homocysteine induced excellent fluorescence recovery towards other reducing materials, such as RSS and various amino acids. Furthermore, the selectivity of CMOS-2 was also studied in the same condition. As expected, CMOS-2 could selectively detect HOCl, and not alter fluorescence intensity under various kinds of biothiols (Fig. S11). Therefore, our design strategy for the on–off–on probe is confirmed by results obtained above, with which CMOS can be utilized for detecting the redox process between HOCl and Cys/Hcy with high selectivity.


image file: c7ra13419c-f3.tif
Fig. 3 (a) Fluorescence response of CMOS (2 μM) to different ROS, RNS and RSS (200 μM). Bars represent emission intensity ratios before (F0) and after (F1) addition of each analytes. (a) HOCl; (b) KO2; (c) H2O2; (d) 1O2; (e) HO·; (f) t-BuOOH; (g) t-BuOO·; (h) NO2; (i) NO3; (j) NO; (k) GSH; (l) Cys; (m) Hcy; (n) Na2S; (o) Na2S2O3; (p) Na2S2O8; (q) NaSCN; (r) DTT; (s) Na2SO3. (b) Fluorescence response of the solution added HOCl in (a) to different RSS and amino acids. Bars represent emission intensity ratios before (F2) and after (F3) addition of each analytes (5 mM). (a) Cys; (b) Hcy; (c) Na2S; (d) Na2S2O3; (e) Na2S2O8; (f) NaSCN; (g) DTT; (h) Na2SO3; (i) Ala; (j) Glu; (k) Gly; (l) His; (m) Ile; (n) Leu; (o) Met; (p) Phe; (q) Pro; (r) Ser; (s) Trp; (t) Vc; (u) GSH. (20 mM PBS buffer/CH3CN, 7[thin space (1/6-em)]:[thin space (1/6-em)]3, v/v, pH = 7.4, λex/λem = 405/480 nm).

Subsequently, the influence of pH on probe CMOS was measured. The fluorescence intensity of CMOS and CMCHO perform no significant variances in wide pH ranges (pH = 4–11, Fig. S12a). Fluorescence intensity changes could be observed immediately when HOCl was added into the solution of probe CMOS, especially in alkaline condition (Fig. 4a). Considering the pKa of HOCl is 7.6,29 CMOS is responsive to both HOCl and OCl. Alkaline condition was also benefit for the fluorescence recovery of CMOS from Cys/Hcy (Fig. S12b). It is reasonable to consider that thiol atom displays higher nucleophilicity in alkaline condition. From the stop-flow test, the UV-visible absorbance of probe CMOS sharply decreased at the wavelength of 400 nm (Fig. 4b). The response time was within 10 s and the kinetic of the reaction was fitted to a single exponential function (kobs = 0.67 s−1). The ability of instantaneous response is extremely necessary to intracellular HOCl detection.


image file: c7ra13419c-f4.tif
Fig. 4 (a) Fluorescence responses of CMOS to HOCl under different pH values. Squares represent emission intensity ratios after (F1) and before (F0) addition of 200 μM HOCl (λex/λem = 405/480 nm). (b) Time-dependent changes in the absorption intensity of CMOS (1 μM) before and after addition of HOCl. (20 mM PBS buffer/CH3CN, 7[thin space (1/6-em)]:[thin space (1/6-em)]3, v/v, pH = 7.4, λabs = 400 nm).

With these data in hand, we next applied CMOS for fluorescence imaging of the redox changes with HOCl and Cys/Hcy in living cells. After incubation with 5 μM CMOS at 37 °C for 30 min, intense fluorescence was observed of the SKVO-3 cells in the optical window 425–525 nm (Fig. 5a and d), indicating the probe can easily penetrate into cells. Treating the cells with 100 μM NaOCl led to remarkable fluorescence quenching as the probe sensed the HOCl-induced oxidative stress (Fig. 5b and e). After 3 min, the cells were washed with PBS buffer three times, and added 5 mM Cys/Hcy for 1 h, respectively. Then the fluorescence was recovered obviously (Fig. 5c and f). Experimental results clearly declare that the probe CMOS was successfully used to detect the process of HOCl oxidative stress and Cys/Hcy reducing repair in living cells.


image file: c7ra13419c-f5.tif
Fig. 5 Fluorescence imaging of the process of HOCl oxidative stress and thiols repair in CMOS-labeled SKVO-3 cells. Fluorescence images of SKVO-3 cells loaded with 5 μM CMOS at 37 °C for 30 min (a and d). Dye-loaded cells treated with 100 μM NaOCl at 25 °C for 3 min (b and e). Dye-loaded, NaOCl-treated cell incubated with 5 mM Cys (c), 5 mM Hcy (f) for 1 h. Emission intensities were collected in an optical window 425–525 nm, λex = 405 nm, intensity bar: 0–3900.

Conclusions

In this work, a novel on–off–on fluorescent probe was reported for highly selective detection HOCl oxidative stress and Cys/Hcy reducing repair in vivo and in vitro. The probe CMOS can be easily synthesized and displayed high sensitivity, fast response, and high selectivity. Cells images indicated that CMOS was capable to sense the redox changes between HOCl and Cys/Hcy. Results show that the probe CMOS would be a potential tool to study the oxidative damage and biothiols repairs in the biology and medical research.

Conflicts of interest

There are no conflicts to declare.

Acknowledgements

We greatly acknowledge partial financial support from the NSF of China (21572072), the Science and Technology Innovation Program of the Universities of Henan Province (16HASTIT007), and Zhengzhou University. We also thank Dr Yang Mi and his research team from School of Basic Medical Sciences, Zhengzhou University, for providing SKVO-3 cells in this work.

Notes and references

  1. (a) R. S. Balaban, S. Nemoto and T. Finkel, Cell, 2005, 120, 483–495 CrossRef CAS PubMed; (b) S. G. Rhee, Science, 2006, 312, 1882–1883 CrossRef PubMed; (c) M. T. Lin and M. F. Beal, Nature, 2006, 443, 787–795 CrossRef CAS PubMed; (d) N. E. Sharpless and R. A. DePinho, Nat. Rev. Mol. Cell Biol., 2007, 8, 703–713 CrossRef CAS PubMed; (e) M. E. Goetz and A. Luch, Cancer Lett., 2008, 266, 73–83 CrossRef CAS PubMed; (f) W. Dröge, Physiol. Rev., 2002, 82, 47–95 CrossRef PubMed.
  2. (a) C. C. Winterbourn, M. B. Hampton, J. H. Livesey and A. J. Kettle, J. Biol. Chem., 2006, 281, 39860–39869 CrossRef CAS PubMed; (b) J. Shepherd, S. A. Hilderbrand, P. Waterman, J. W. Heinecke, R. Weissleder and P. Libby, Chem. Biol., 2007, 14, 1221–1231 CrossRef CAS PubMed; (c) S. Khatib, R. Musa and J. Vaya, Bioorg. Med. Chem., 2007, 15, 3661–3666 CrossRef CAS PubMed; (d) Z. M. Prokopowicz, F. Arce, R. Biedron, C. L. Chiang, M. Ciszek, D. R. Katz, M. Nowakowska, S. Zapotoczny, J. Marcinkiewicz and B. M. Chain, J. Immunol., 2010, 184, 824–835 CrossRef CAS PubMed.
  3. (a) E. Hidalgo, R. Bartolome and C. Dominguez, Chem.-Biol. Interact., 2002, 139, 265–282 CrossRef CAS PubMed; (b) D. I. Pattison and M. J. Davies, Chem. Res. Toxicol., 2001, 14, 1453–1464 CrossRef CAS PubMed; (c) P. J. O'Brien, Chem.-Biol. Interact., 2000, 129, 113–139 CrossRef.
  4. Y. W. Yap, M. Whiteman and N. S. Cheung, Cell. Signalling, 2007, 19, 219–228 CrossRef CAS PubMed.
  5. J. H. Limón-Pacheco and M. E. Gonsebatt, Cent. Nerv. Syst. Agents Med. Chem., 2010, 10, 287–297 CrossRef.
  6. Y. Maruyama, B. Lindholm and P. J. Stenvinkel, Nephrology, 2004, 17, S72–S76 CAS.
  7. C. A. Lang, B. J. Mills, W. Mastropaolo and M. C. Liu, J. Lab. Clin. Med., 2000, 135, 402–405 CrossRef CAS PubMed.
  8. D. I. Pattison and M. J. Davies, Biochemistry, 2006, 45, 8152–8162 CrossRef CAS PubMed.
  9. (a) M. Valko, D. Leibfritz, J. Moncol, M. T. D. Cronin, M. Mazur and J. Telser, Int. J. Biochem. Cell Biol., 2007, 39, 44–84 CrossRef CAS PubMed; (b) D. P. Jones, Antioxid. Redox Signaling, 2006, 8, 1865–1879 CrossRef CAS PubMed; (c) J. Nordberg and E. S. Arner, J. Free Radicals Biol. Med., 2001, 31, 1287–1312 CrossRef CAS.
  10. (a) T. D. Ashton, K. A. Jolliffe and F. M. Pfeffer, Chem. Soc. Rev., 2015, 44, 4547–4595 RSC; (b) K. P. Carter, A. M. Young and A. E. Palmer, Chem. Rev., 2014, 114, 4564–4601 CrossRef CAS PubMed; (c) X. Chen, X. Tian, I. Shin and J. Yoon, Chem. Soc. Rev., 2011, 40, 4783–4804 RSC; (d) X. Chen, F. Wang, J. Y. Hyun, T. Wei, J. Qiang, X. Ren, I. Shin and J. Yoon, Chem. Soc. Rev., 2016, 45, 2976–3016 RSC; (e) M. S. Goncalves, Chem. Rev., 2009, 109, 190–212 CrossRef CAS PubMed; (f) Y. Tang, D. Lee, J. Wang, G. Li, J. Yu, W. Lin and J. Yoon, Chem. Soc. Rev., 2015, 44, 5003–5015 RSC; (g) M. Vendrell, D. Zhai, J. C. Er and Y. T. Chang, Chem. Rev., 2012, 112, 4391–4420 CrossRef CAS PubMed; (h) J. Yin, Y. Hu and J. Yoon, Chem. Soc. Rev., 2015, 44, 4619–4644 RSC; (i) L. Yuan, W. Lin, K. Zheng, L. He and W. Huang, Chem. Soc. Rev., 2013, 42, 622–661 RSC; (j) L. Wang, W. Li, W. Zhi, D. Ye, W. Zhang and L. Ni, Sens. Actuators, B, 2018, 255, 1112–1118 Search PubMed; (k) X. Zhou, S. Lee, Z. Xu and J. Yoon, Chem. Rev., 2015, 115, 7944–8000 CrossRef CAS PubMed.
  11. (a) J. T. Hou, K. Li, J. Yang, K. K. Yu, Y. X. Liao, Y. Z. Ran, Y. H. Liu, X. D. Zhou and X. Q. Yu, Chem. Commun., 2015, 51, 6781–6784 RSC; (b) X. Chen, K. A. Lee, E. M. Ha, K. M. Lee, Y. Y. Seo, H. K. Choi, H. N. Kim, M. J. Kim, C. S. Cho, S. Y. Lee, W. J. Lee and J. Yoon, Chem. Commun., 2011, 47, 4373–4375 RSC; (c) M. Sun, H. Yu, H. Zhu, F. Ma, S. Zhang, D. Huang and S. Wang, Anal. Chem., 2014, 86, 671–677 CrossRef CAS PubMed; (d) J. J. Hu, N. K. Wong, M. Y. Lu, X. M. Chen, S. Ye, A. Q. Zhao, P. Gao, R. Yi-Tsun Kao, K. Yi-Tsun, J. G. Shen and D. Yang, Chem. Sci., 2016, 7, 2094–2099 RSC; (e) Y. S. Kim, M. Choi, S. T. Manjare, S. Y. Jon and D. G. Churchill, RSC Adv., 2016, 6, 32013–32017 RSC; (f) Y. R. Zhang, Z. M. Zhao, L. Su, J. Y. Miao and B. X. Zhao, RSC Adv., 2016, 6, 17059–17063 RSC; (g) S. Y. Yu, C. Y. Hsu, W. C. Chen, L. F. Wei and S. P. Wu, Sens. Actuators, B, 2014, 196, 203–207 CrossRef CAS; (h) B. P. Guo, H. L. Nie, W. Yang, Y. Tian, J. Jing and X. L. Zhang, Sens. Actuators, B, 2016, 236, 459–465 CrossRef CAS; (i) Q. A. Best, N. Sattenapally, D. J. Dyer, C. N. Scott and M. E. McCarroll, J. Am. Chem. Soc., 2013, 135, 13365–13370 CrossRef CAS PubMed; (j) Y. Koide, Y. Urano, K. Hanaoka, T. Terai and T. Nagano, J. Am. Chem. Soc., 2011, 133, 5680–5682 CrossRef CAS PubMed; (k) R. Zhang, J. Zhao, G. Han, Z. Liu, C. Liu, C. Zhang, B. Liu, C. Jiang, R. Liu, T. Zhao, M. Y. Han and Z. Zhang, J. Am. Chem. Soc., 2016, 138, 3769–3778 CrossRef CAS PubMed; (l) J. H. Lee, C. S. Lim, Y. S. Tian, J. H. Han and B. R. Cho, J. Am. Chem. Soc., 2010, 132, 1216–1217 CrossRef CAS PubMed; (m) M. Isik, R. Guliyev, S. Kolemen, Y. Altay, B. Senturk, T. Tekinay and E. U. Akkaya, Org. Lett., 2014, 16, 3260–3263 CrossRef CAS PubMed; (n) X. Y. Han, F. B. Yu, X. Y. Song and L. X. Chen, Chem. Sci., 2016, 7, 5098–5107 RSC; (o) D. H. Yu, Q. Zhang, S. S. Ding and G. Q. Feng, RSC Adv., 2014, 4, 46561–46577 RSC.
  12. (a) H.-L. Gong, Y. Jiang, R.-C. Hou and X.-Q. Ding, J. Fluoresc., 2016, 26, 403–406 CrossRef CAS PubMed; (b) J. Fan, H. Mu, H. Zhu, J. Wang and X. Peng, Analyst, 2015, 140, 4594–4598 RSC; (c) Y. Liu, Z.-M. Zhao, J.-Y. Miao and B.-X. Zhao, Anal. Chim. Acta, 2016, 921, 77–83 CrossRef CAS PubMed.
  13. Z. N. Sun, F. Q. Liu, Y. Chen, P. K. Tam and D. Yang, Org. Lett., 2008, 10, 2171–2174 CrossRef CAS PubMed.
  14. M. L. Aulsebrook, B. Graham, M. R. Grace and K. L. Tuck, Supramol. Chem., 2015, 27, 798–806 CrossRef.
  15. (a) X. Chen, X. Wang, S. Wang, W. Shi, K. Wang and H. Ma, Chem.–Eur. J., 2008, 14, 4719–4724 CrossRef CAS PubMed; (b) L. Wang, W. Li, W. Zhi, D. Ye, W. Zhang and L. Ni, Sens. Actuators, B, 2018, 255, 1112–1118 CrossRef CAS.
  16. (a) Z. Luo, P. Li, Q. Pan and K. Han, Chem. Commun., 2013, 49, 2445–2447 RSC; (b) G. Cheng, J. Fan, W. Sun, J. Cao, C. Hu and X. Peng, Chem. Commun., 2014, 50, 1018–1020 RSC.
  17. (a) S. Kenmoku, Y. Urano, H. Kojima and T. Nagano, J. Am. Chem. Soc., 2007, 129, 7313–7318 CrossRef CAS PubMed; (b) L. Liang, C. Liu, X. Jiao, L. Zhao and X. Zeng, Chem. Commun., 2016, 52, 7982–7985 RSC.
  18. X. Cheng, H. Jia, T. Long, J. Feng, J. Qin and Z. Li, Chem. Commun., 2011, 47, 11978–11980 RSC.
  19. (a) Z. Zhang, Y. Zheng, W. Hang, X. Yan and Y. Zhao, Talanta, 2011, 85, 779–786 CrossRef CAS PubMed; (b) Z. Zhang, C. Deng, L. Meng, Y. Zheng and X. Yan, Anal. Methods, 2015, 7, 107–114 RSC.
  20. (a) L. Yuan, W. Lin, J. Song and Y. Yang, Chem. Commun., 2011, 47, 12691–12693 RSC; (b) E. Wang, H. Qiao, Y. Zhou, L. Pang, F. Yu, J. Zhang and T. Ma, RSC Adv., 2015, 5, 73040–73045 RSC.
  21. (a) W. Zhang, W. Liu, P. Li, J. Kang, J. Wang, H. Wang and B. Tang, Chem. Commun., 2015, 51, 10150–10153 RSC; (b) W. Zhang, P. Li, F. Yang, X. Hu, C. Sun, W. Zhang, D. Chen and B. Tang, J. Am. Chem. Soc., 2013, 135, 14956–14959 CrossRef CAS PubMed; (c) F. Yu, P. Li, B. Wang and K. Han, J. Am. Chem. Soc., 2013, 135, 7674–7680 CrossRef CAS PubMed; (d) F. Yu, P. Li, P. Song, B. Wang, J. Zhao and K. Han, Chem. Commun., 2012, 48, 4980–4982 RSC; (e) F. Yu, P. Li, G. Li, G. Zhao, T. Chu and K. Han, J. Am. Chem. Soc., 2011, 133, 11030–11033 CrossRef CAS PubMed; (f) K. Xu, M. Qiang, W. Gao, R. Su, N. Li, Y. Gao, Y. Xie, F. Kong and B. Tang, Chem. Sci., 2013, 4, 1079–1086 RSC; (g) K. Xu, H. Chen, J. Tian, B. Ding, Y. Xie, M. Qiang and B. Tang, Chem. Commun., 2011, 47, 9468–9470 RSC; (h) B. Wang, P. Li, F. Yu, P. Song, X. Sun, S. Yang, Z. Lou and K. Han, Chem. Commun., 2013, 49, 1014–1016 RSC; (i) Y. Shen, X. Zhang, X. Huang, S. Wen, M. Liu, Y. Deng, Y. Zhang, C. Zhang, J. Jin, H. Li and S. Yao, RSC Adv., 2015, 5, 79519–79524 RSC; (j) Z. Qu, J. Ding, M. Zhao and P. Li, J. Photochem. Photobiol., A, 2015, 299, 1–8 CrossRef CAS; (k) E. W. Miller, S. X. Bian and C. J. Chang, J. Am. Chem. Soc., 2007, 129, 3458–3459 CrossRef CAS PubMed; (l) Z. Lou, P. Li, X. Sun, S. Yang, B. Wang and K. Han, Chem. Commun., 2013, 49, 391–393 RSC; (m) S. R. Liu and S. P. Wu, Org. Lett., 2013, 15, 878–881 CrossRef CAS PubMed.
  22. (a) K. P. Bhabak and G. Mugesh, Acc. Chem. Res., 2010, 43, 1408–1419 CrossRef CAS PubMed; (b) Z. Lou, P. Li and K. Han, Acc. Chem. Res., 2015, 48, 1358–1368 CrossRef CAS PubMed; (c) G. Mugesh, W.-W. du Mont and H. Sies, Chem. Rev., 2001, 101, 2125–2180 CrossRef CAS PubMed; (d) V. Nascimento, E. E. Alberto, D. W. Tondo, D. Dambrowski, M. R. Detty, F. Nome and A. L. Braga, J. Am. Chem. Soc., 2012, 134, 138–141 CrossRef CAS PubMed; (e) B. K. Sarma and G. Mugesh, J. Am. Chem. Soc., 2005, 127, 11477–11485 CrossRef CAS PubMed.
  23. S. Shahrokhian, Anal. Chem., 2001, 73, 5972–5978 CrossRef CAS PubMed.
  24. H. Refsum and P. M. Ueland, Annu. Rev. Med., 1998, 49, 31–62 CrossRef CAS PubMed.
  25. S. Seshadri, A. Beiser, J. Selhub, P. F. Jacques, I. H. Rosenberg, R. B. D'Agostino, P. W. F. Wilson and P. A. Wolf, N. Engl. J. Med., 2002, 346, 476–483 CrossRef CAS PubMed.
  26. (a) X. Wu, Z. Li, L. Yang, J. Han and S. Han, Chem. Sci., 2013, 4, 460–467 RSC; (b) Q. Xu, K. A. Lee, S. Lee, K. M. Lee, W. J. Lee and J. Yoon, J. Am. Chem. Soc., 2013, 135, 9944–9949 CrossRef CAS PubMed; (c) L. Yuan, L. Wang, B. K. Agrawalla, S. J. Park, H. Zhu, B. Sivaraman, J. Peng, Q. H. Xu and Y. T. Chang, J. Am. Chem. Soc., 2015, 137, 5930–5938 CrossRef CAS PubMed; (d) F. Liu, Y. Tang, Y. Kuang, D. Pan, X. Liu, R. Q. Yu and J. H. Jiang, RSC Adv., 2016, 6, 107910–107915 RSC; (e) Y. W. Jun, S. Sarkar, S. Singha, Y. J. Reo, H. R. Kim, J. J. Kim, Y. T. Chang and K. H. Ahn, Chem. Commun., 2017, 53, 10800–10803 RSC.
  27. (a) C. Yang, X. Wang, L. Shen, W. Deng, H. Liu, S. Ge, M. Yan and X. Song, Biosens. Bioelectron., 2016, 80, 17–23 CrossRef CAS PubMed; (b) W. Lin, L. Long, L. Yuan, Z. Cao, B. Chen and W. Tan, Org. Lett., 2008, 10, 5577–5580 CrossRef CAS PubMed; (c) O. Rusin, N. N. St Luce, R. A. Agbaria, J. O. Escobedo, S. Jiang, I. M. Warner, F. B. Dawan, K. Lian and R. M. Strongin, J. Am. Chem. Soc., 2004, 126, 438–443 CrossRef CAS PubMed; (d) R. D. Hanna, Y. Naro, A. Deiters and P. E. Floreancig, J. Am. Chem. Soc., 2016, 138, 13353–13360 CrossRef CAS PubMed; (e) C. C. Chang, F. Wang, J. Qiang, Z. J. Zhang, Y. H. Chen, W. Zhang, Y. Wang and X. Q. Chen, Sens. Actuators, B, 2017, 243, 22–28 CrossRef CAS.
  28. (a) T.-K. Kim, D.-N. Lee and H.-J. Kim, Tetrahedron Lett., 2008, 49, 4879–4881 CrossRef CAS; (b) S. R. Bobe, R. S. Bhosale, S. P. Goskulwad, A. L. Puyad, S. V. Bhosale and S. V. Bhosale, RSC Adv., 2015, 5, 100697–100701 RSC.
  29. G. Li, D. Zhu, Q. Liu, L. Xue and H. Jiang, Org. Lett., 2013, 15, 2002–2005 CrossRef CAS PubMed.

Footnote

Electronic supplementary information (ESI) available: NMR and mass spectra, and additional UV and fluorescence data. See DOI: 10.1039/c7ra13419c

This journal is © The Royal Society of Chemistry 2018